CRANPAC D TABLET-10 tablets -IPCA Labs’

CRANPAC D TABLET – Ipca Laboratories Ltd


Offer: 3.1%

FORM – (10 tablet in strip)

COMPOSITION -Cranberry PAC and D-Mannose.

COMPANY NAME – Ipca Laboratories Ltd


Qty - +


Cranpac-D tablet is formulated with Cranberry PAC and D-Mannose. Cranpac-D prevents adhesion of Uro Pathogenic E.Coli (UPEC) through both P-type & Type-1 pili. D-Mannose in Cranpac-D prevents attachment of UPEC on bladder walls, and prevents cystitis (Bladder infections) and
Cranberry prevents attachment of UPEC to the kidney walls, thereby preventing pyelonephritis (Kidney infections).
Cranpac D Tablet Uses
Cranpac D Tablet is used in the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:
Urinary tract infections
Cranpac D Tablet Working
Cranpac D Tablet improves the patient’s condition by performing the following functions on the body:
Keeping bacteria from sticking to the lining in the urinary tract.
Cranpac D Tablet Side Effects
The following is an exhaustive list of side-effects that may occur for all the constituting molecules of Cranpac D Tablet. Some of these side-effects may be very rare or not found if the salt or molecule is in trace amounts. Not every side effect occurs in every person. Medicines that are approved for sale by governments are expected to be safe for the general population, although new or un-reported side effects may be found later. Please consult your doctor if you observe any of these side effects even in mild form:
Loose stoolsCranpac D Tablet Composition
Cranpac D Tablet is composed of the following salts:
Cranberry pac

Cranpac D Tablet Packages and Strengths
Cranpac D Tablet is available in the following packages and strengths
Packages: 10 Tablet

Cranpac D Tablet Manufacturers
The medicine is manufactured by the following companies
Ipca Labs

Dosage Information
Please consult your Doctor.